Invention Grant
- Patent Title: Methods and compositions for treatment of metabolic disorders
-
Application No.: US14021825Application Date: 2013-09-09
-
Publication No.: US09907848B2Publication Date: 2018-03-06
- Inventor: Mark A. Exley , Lydia Lynch , Donal O'Shea , Cliona O'Farrelly , Steven P. Balk
- Applicant: Beth Israel Deaconess Medical Center, Inc.
- Applicant Address: US MA Boston
- Assignee: Beth Israel Deaconess Medical Center, Inc.
- Current Assignee: Beth Israel Deaconess Medical Center, Inc.
- Current Assignee Address: US MA Boston
- Agency: Clark & Elbing LLP
- Main IPC: A61K31/7032
- IPC: A61K31/7032 ; A61K45/06 ; A61K39/395 ; A61K31/70 ; A61K35/17
Abstract:
The present invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders such as obesity and diabetes. The invention accordingly features methods, kits, and compositions for the treatment of such metabolic disorders by administration of a composition capable of increasing iNKT activity.
Public/Granted literature
- US20140079771A1 METHODS AND COMPOSITIONS FOR TREATMENT OF METABOLIC DISORDERS Public/Granted day:2014-03-20
Information query
IPC分类:
